Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004961904 | SCV005468800 | uncertain significance | Inborn genetic diseases | 2024-09-26 | criteria provided, single submitter | clinical testing | The c.2042C>T (p.A681V) alteration is located in exon 10 (coding exon 10) of the PKD1 gene. This alteration results from a C to T substitution at nucleotide position 2042, causing the alanine (A) at amino acid position 681 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005017301 | SCV005643161 | likely benign | Polycystic kidney disease, adult type | 2024-05-17 | criteria provided, single submitter | clinical testing |